Calyxt Current Liabilities
Delisted
The Current Liabilities of Calyxt (CLXT) as of Jul 24, 2026 is 1.66 M USD. In the previous year, Current Liabilities was 4.85 M USD — a change of -65.76% (lower).
Get this data via API
Financial Data API
Current Liabilities
1.66 MUSD
YoY
-65.76%
Last updated:
Current Liabilities of Calyxt is 2026 1.66 M USD. Current Liabilities of Calyxt was 2025 4.85 M USD. It decreases by -65.76% lower compared to the previous year.
Access this data via the Eulerpool API
Calyxt Stock analysis
What does Calyxt do? Calyxt Inc. is a US company specializing in the development and marketing of genetically modified plants. The company was founded in Minnesota in 2010 with the aim of producing high-quality, healthy, and environmentally friendly products that meet the requirements of modern and sustainable nutrition.
History
The history of Calyxt Inc. began with the idea of revolutionizing the cultivation of crops. The company was founded by Cellectis SA, which already had experience in the field of molecular biology. Calyxt developed technological processes for rapid genetic manipulation of plants that had the potential to change the entire agricultural industry.
Business Model
Calyxt follows an "end-to-end" business model, meaning the company offers products and services along the entire value chain. This ranges from the development of new plants through genetic modifications to the distribution and marketing of the end products.
Divisions
Calyxt specializes in the development of plant varieties optimized through genetic manipulation. The company has various divisions that focus on specific plant species, including:
- Soybeans: Calyxt has developed a new variety of soybeans that contains a higher proportion of oleic acid, which improves the durability and quality of the beans.
- Wheat: The company has also developed a variety of wheat that is low in gluten. This allows people with celiac disease or other reasons to avoid gluten to consume this variety.
- Potatoes: Calyxt has developed a new variety of potatoes that contains less acrylamide than other varieties. Acrylamide is formed during the production of fries and chips and is suspected to cause cancer.
Products
Calyxt offers various products made from the plants they have developed, including:
- Soybean oil: Calyxt soybean oil contains a higher proportion of healthy omega-3 fatty acids compared to conventional soybean oil.
- Flour: Calyxt wheat flour is low in gluten and can be consumed by people with celiac disease or other reasons to avoid gluten.
- Fries and chips: Calyxt potatoes contain less acrylamide than conventional potatoes, resulting in the formation of fewer harmful substances during the preparation of fries and chips.
Conclusion
Calyxt Inc. is an American company that develops genetically modified plants and connects them with customers, mainly in the food sector. The company aims to produce healthy, environmentally friendly, and high-quality products that meet the requirements of modern and sustainable nutrition. Various plant species are genetically modified to improve the durability and quality of the products while minimizing health risks. Calyxt Inc. offers various products made from the plants they have developed, with a focus on the production of fries and chips, as well as the distribution of soybean oil and low-gluten wheat flour. Calyxt has the potential to change modern agriculture through its innovative and sustainable products. Calyxt is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Calyxt stock
Current Liabilities of Calyxt is 1.66 M USD in 2026.
Access this data via the Eulerpool API
Balance Sheet — Calyxt
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Calyxt
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth